The role of Lactobacillus in dibutyl phthalate-induced gut and liver injury: Probiotic intervention and multi-omics evidence

Read full text Summarise with VIRAT
Authors: Siming Huo, Bo Li, Jiayu Du, Zheng Cao
Cited by: 0
References: 33

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Dibutyl phthalate (DBP), a widespread environmental contaminant, induces hepatotoxicity. While the gut-liver axis is implicated, the specific role of gut microbiota, particularly key beneficial genera, remains obscure. This study aimed to elucidate whether Lactobacillus depletion is a central event in DBP-induced gut-liver axis disruption and to evaluate the therapeutic potential of probiotic intervention. Mice were exposed to DBP (0, 50, 100, 200 mg/kg/day) for 28 days. An intervention group received DBP (100 mg/kg/day) co-administered with Lactobacillus rhamnosus GG (LGG, 1 ×10 9 CFU/day). Systemic toxicity was assessed via serum biochemistry and histopathology. Gut barrier integrity, oxidative stress, and inflammation were evaluated in the ileum and liver. Multi-omics analyses, including 16S rDNA sequencing of ileal microbiota, liver transcriptomics, and serum metabolomics, were integrated to uncover mechanistic links. DBP exposure induced dose-dependent hepatotoxicity (steatosis, elevated ALT/AST, oxidative stress, inflammation) and ileal injury (barrier disruption, dysbiosis). Crucially, DBP specifically and significantly depleted ileal Lactobacillus . Multi-omics integration revealed that Lactobacillus depletion was strongly correlated with disrupted sphingolipid metabolism, a pathway concurrently altered in the serum metabolome and liver transcriptome. Intervention with LGG significantly ameliorated both intestinal barrier dysfunction (restored tight junctions, reduced permeability) and hepatic injury (attenuated steatosis, oxidative stress, and inflammation). Our findings demonstrate that DBP-induced hepatotoxicity is mediated, in part, through the specific depletion of intestinal Lactobacillus , leading to gut barrier failure and systemic metabolic disturbances, notably in sphingolipid signaling. Probiotic supplementation with LGG effectively counteracts these defects. This study identifies Lactobacillus as a critical target of DBP and highlights microbiota-directed strategies as a promising avenue for mitigating phthalate toxicity. • DBP exposure specifically depletes Lactobacillus in the ileum. • DBP-induced Lactobacillus loss disrupts sphingolipid metabolism. • Probiotic LGG counteracts DBP-induced gut barrier damage. • LGG intervention alleviates DBP-induced hepatic steatosis and inflammation. • DBP hepatotoxicity is mediated through Lactobacillus via gut-liver axis.

Fields of Study & Subjects

Gut microbiota and health Probiotics and Fermented Foods Drug-Induced Hepatotoxicity and Protection

Publication details

Journal / source
Ecotoxicology and Environmental Safety
Volume
314
Pages
120051–120051
Publication date
27 March 2026
Language
EN